Cargando…

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma

BACKGROUND: Live attenuated influenza vaccine (LAIV) is recommended for annual influenza vaccination in children from age 2 years. However, some guidelines recommend against its use in children with asthma or recurrent wheeze due to concerns over its potential to induce wheezing. OBJECTIVE: We sough...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Paul J., Fleming, Louise, Saglani, Sejal, Southern, Jo, Andrews, Nick J., Miller, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mosby 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156909/ https://www.ncbi.nlm.nih.gov/pubmed/31863808 http://dx.doi.org/10.1016/j.jaci.2019.12.010

Ejemplares similares

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
por: Turner, P. J., et al.
Publicado: (2019)

Safety of live attenuated influenza vaccine in atopic children with egg allergy
por: Turner, Paul J., et al.
Publicado: (2015)

Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
por: Turner, Paul J, et al.
Publicado: (2015)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023)

Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2–16 years after successive annual vaccinations with LAIV
por: Hoschler, Katja, et al.
Publicado: (2020)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
por: Sinnathamby, Mary A., et al.
Publicado: (2023)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

985. Safety of Guidelines Recommending LAIV for Routine Use in Children and Adolescents With Asthma
por: Nordin, James, et al.
Publicado: (2018)

The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
por: Rose, Markus A, et al.
Publicado: (2014)

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2018)

Advances in the pathogenesis and personalised treatment of paediatric asthma
por: Scotney, Elizabeth, et al.
Publicado: (2023)

Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom
por: Jackson, David, et al.
Publicado: (2020)

Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink
por: Caspard, Herve, et al.
Publicado: (2018)

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
por: Tarride, Jean-Eric, et al.
Publicado: (2012)

Correction: Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink
Publicado: (2019)

Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Li, et al.
Publicado: (2022)

664 Influenza Vaccination in Chronically Ill Children: Taking a Closer Look at LAIV
por: Merckx, Joanna, et al.
Publicado: (2014)

An approach to the management of children with problematic severe asthma
por: Fainardi, Valentina, et al.
Publicado: (2020)

1060 The Effect of Live Attenuated Influenza Vaccine (LAIV) on Bacterial Colonization in Healthy 2-4 Year Old Children. A Randomised Controlled Study
por: Thors, Valtyr, et al.
Publicado: (2014)

Paediatric severe asthma biologics service: from hospital to home
por: Makhecha, Sukeshi, et al.
Publicado: (2021)

Approaches to Asthma Diagnosis in Children and Adults
por: Saglani, Sejal, et al.
Publicado: (2019)

Mechanisms Mediating Pediatric Severe Asthma and Potential Novel Therapies
por: Martin Alonso, Aldara, et al.
Publicado: (2017)

Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children
por: Ang, Jann Catherine, et al.
Publicado: (2019)

1663. Marked Improvement in Pandemic H1N1 Component Shedding and Immunogenicity in 2017–2018 Russian-Backbone Live Attenuated Influenza Vaccine (LAIV) in Gambian Children
por: Lindsey, Benjamin, et al.
Publicado: (2018)

Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids
por: Nagakumar, Prasad, et al.
Publicado: (2019)

An Alarmin Role for P2Y(13) Receptor during Viral-driven Asthma Exacerbations
por: Byrne, Adam J., et al.
Publicado: (2021)

Asthma: Closing in on the Biology of a Complex Life-course Disease
por: Bush, Andrew, et al.
Publicado: (2023)

Managing the pediatric patient with refractory asthma: a multidisciplinary approach
por: Cook, James, et al.
Publicado: (2017)

Current Opinion in LAIV: A Matter of Parent Virus Choice
por: Kiseleva, Irina
Publicado: (2022)

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing
por: Ambrose, C. S., et al.
Publicado: (2012)

Primary care of children and young people with asthma during the COVID-19 era
por: Creese, Hanna, et al.
Publicado: (2020)

Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
por: Isakova-Sivak, Irina, et al.
Publicado: (2014)

Remodeling Phenotypes Take Center Stage in the Prediction of Preschool Wheeze Attacks
por: Saglani, Sejal, et al.
Publicado: (2022)

Application of Metabolomics in Obesity-Related Childhood Asthma Subtyping: A Narrative Scoping Review
por: Makrinioti, Heidi, et al.
Publicado: (2023)

Disadvantage in early-life and persistent asthma in adolescents: a UK cohort study
por: Creese, Hanna, et al.
Publicado: (2022)

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation
por: Moeller, Alexander, et al.
Publicado: (2015)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33
por: Castanhinha, Susana, et al.
Publicado: (2015)

Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing
por: Ambrose, Christopher S.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2i4dsdrdg0dup1qe5rs9i9s1mc